Researcher
Lize Bollen
- Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Pharmaceutics, Drug discovery and development
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Apr 2013 → 30 Sep 2015
Projects
1 - 1 of 1
- Role of PAI-1 and TAFI in the aetiology of IBD and as prognostic marker or/and therapeutic target to prevent venous thromboembolism in IBD patients.From1 Oct 2011 → 30 Sep 2015Funding: FWO fellowships
Publications
1 - 10 of 11
- Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation(2016)
Authors: Thomas Van Stappen, Lize Bollen, Niels Vande Casteele, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
- Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profile(2016)
Authors: Lize Bollen, Joke Wuyts, Séverine Vermeire, Ann Gils
Pages: 223 - 5 - Analytical and clinical validation of a rapid point-of-care assay for infliximab quantification in patients with ulcerative colitis(2016)
Authors: Thomas Van Stappen, Lize Bollen, Niels Vande Casteele, Konstantinos Papamichael, Nick Geukens, Chris Barthel, Yessica Kölmel, Nasim Zali, Steffen Rameil, Gert Van Assche, et al.
Pages: S145 - S145 - Thromboembolism as an important complication of inflammatory bowel disease(2016)
Authors: Lize Bollen, Niels Vande Casteele, Vera Ballet, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pages: 1 - 7 - The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile(2015)
Authors: Lize Bollen, Niels Vande Casteele, Gert Van Assche, Marc Ferrante, Paul Declerck, Séverine Vermeire, Ann Gils
Pages: 2540 - 8 - Short-term Effect of Infliximab Is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease: A Prospective Study(2015)
Authors: Lize Bollen, Niels Vande Casteele, Kristel Van Steen, Paul Rutgeerts, Marc Ferrante, Marc Hoylaerts, Séverine Vermeire, Ann Gils
Pages: 570 - 8 - Active PAI-1 as marker for venous thromboembolism: Case-control study using a comprehensive panel of PAI-1 and TAFI assays(2014)
Authors: Lize Bollen, Marijke Peetermans, Kristel Van Steen, Marc Hoylaerts, Paul Declerck, Peter Verhamme, Ann Gils
Pages: 1097 - 102 - PRIMARY RESPONSE TO INFLIXIMAB THERAPY IN IBD PATIENTS IS REFLECTED IN THE NORMALISATION OF THE HAEMOSTATIC PROFILE(2014)
Authors: Lize Bollen, Niels Vande Casteele, M Peeters, Paul Declerck, Marc Ferrante, Séverine Vermeire, Ann Gils
Pages: S6 - S7 - ACTIVE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) CONCENTRATIONS ARE INCREASED IN PATIENTS WITH A VENOUS THROMBOEMBOLISM (VTE)(2014)
Authors: Lize Bollen, M Peeters, Marc Hoylaerts, Paul Declerck, Peter Verhamme, Ann Gils
Pages: S7 - S7 - Primary response to infliximab therapy in IBD patients is reflected in the normalisation of the haemostatic profile(2014)
Authors: Lize Bollen, Niels Vande Casteele, M Peeters, Paul Declerck, Marc Ferrante, Séverine Vermeire, Ann Gils
Pages: S221 - S222